Can a web app get people moving in mental health residential care?

NCT ID NCT07746609

Completed Symptom relief Sponsor: Munster Technological University Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This trial is testing a web-based app called Active Ease, designed to help people with severe mental illness living in residential care become more physically active. The app includes educational content and guided exercise demonstrations. Researchers will compare two residential houses using the app against one house receiving usual care, measuring physical activity levels and gathering feedback from participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Active Ease, a co-designed web-based digital physical activity application with guided visual demonstrations
What this could lead to: If effective, this digital tool could offer a practical way to help people with severe mental illness in residential care become more physically active, potentially improving their overall health and well-being.
What could go wrong: This is a small early-stage study with only 18 participants, so results may not apply broadly. The intervention's success depends on user engagement and may not lead to lasting changes in physical activity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder Motor Activity psychiatric disorder psychotic disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTH PROFESSIONALS SEVERE MENTAL ILLNESS

Contacts and locations

Locations

Munster Technological University

Cork, T12P928, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.